These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2065946)
1. [Effect of chemoimmunotherapy on the sensitivity of T-lymphocytes to theophylline in lymphoma]. Bratus' GG; Darchuk GF Gematol Transfuziol; 1991 Jan; 36(1):32-4. PubMed ID: 2065946 [TBL] [Abstract][Full Text] [Related]
2. [The effect of immunotherapy on the T system in lymphoma based on data from the theophylline test]. Bratus' GG; Darchuk GF Vrach Delo; 1990 Jan; (1):88-90. PubMed ID: 2330723 [TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma. Gold JE; Zachary DT; Osband ME Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164 [TBL] [Abstract][Full Text] [Related]
4. [The function of the T immunity system in patients with hemoblastoses undergoing polychemotherapy]. Zverkova AS; Bratus' GG Vrach Delo; 1991 Feb; (2):39-43. PubMed ID: 2058119 [TBL] [Abstract][Full Text] [Related]
5. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma. Fass L; Fefer A Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591 [No Abstract] [Full Text] [Related]
6. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice. Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316 [TBL] [Abstract][Full Text] [Related]
7. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor. Hornung RL; Longo DL; Bowersox OC; Kwak LW J Natl Cancer Inst; 1995 Sep; 87(17):1289-96. PubMed ID: 7544833 [TBL] [Abstract][Full Text] [Related]
8. Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma. Gold JE; Zachary DT; Osband ME Clin Immunol Immunopathol; 1994 Oct; 73(1):115-22. PubMed ID: 7923908 [TBL] [Abstract][Full Text] [Related]
9. Models of adoptive T-cell-mediated regression of established tumors. North RJ Contemp Top Immunobiol; 1984; 13():243-57. PubMed ID: 6610533 [No Abstract] [Full Text] [Related]
10. Spontaneous "in vitro" variations of theophylline sensitivity in human peripheral blood lymphocytes. Ciboddo GF; Gromo G; Barbieri MC; Crosti F; Ferrero ME; Besana C; Rugarli C Boll Ist Sieroter Milan; 1983 May; 62(2):190-4. PubMed ID: 6313016 [TBL] [Abstract][Full Text] [Related]
11. Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice. Bortin MM; Truitt RL; Rose WC; Rimm AA; Saltzstein EC Adv Exp Med Biol; 1976; 73 Pt B():331-9. PubMed ID: 793340 [No Abstract] [Full Text] [Related]
12. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide. Naito K; Pellis NR; Kahan BD Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158 [TBL] [Abstract][Full Text] [Related]
13. Adoptive chemoimmunotherapy of a Moloney lymphoma. Fefer A Int J Cancer; 1971 Nov; 8(3):364-73. PubMed ID: 5137306 [No Abstract] [Full Text] [Related]
14. Targeted delivery of tumor necrosis factor-alpha to tumor vessels induces a therapeutic T cell-mediated immune response that protects the host against syngeneic tumors of different histologic origin. Balza E; Mortara L; Sassi F; Monteghirfo S; Carnemolla B; Castellani P; Neri D; Accolla RS; Zardi L; Borsi L Clin Cancer Res; 2006 Apr; 12(8):2575-82. PubMed ID: 16638868 [TBL] [Abstract][Full Text] [Related]
15. Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors. Tong Y; Song W; Crystal RG Cancer Res; 2001 Oct; 61(20):7530-5. PubMed ID: 11606390 [TBL] [Abstract][Full Text] [Related]
16. Surface antigens of theophylline-resistant and theophylline-sensitive human E rosette-forming T lymphocytes. Skopinska-Rózewska E; Ettenger RB; Plaeger-Marshall S; Sieniawska M; Fine RN Folia Biol (Praha); 1988; 34(1):58-62. PubMed ID: 2968929 [TBL] [Abstract][Full Text] [Related]
17. Theophylline-sensitive and theophylline-resistant E-rosette-forming cells in leprosy. Dang DT; Pham MH; Hoang TL; Nguyen HH; Phan LT; Wright EP Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):251-3. PubMed ID: 6609894 [No Abstract] [Full Text] [Related]
18. Potentiation of adoptive immunotherapy by cis-diamminedichloroplatinum(II), but not by doxorubicin, on a disseminated mouse lymphoma and its association with reduction of tumor burden. Formelli F; Rossi C; Sensi ML; Parmiani G Int J Cancer; 1988 Dec; 42(6):952-7. PubMed ID: 3263956 [TBL] [Abstract][Full Text] [Related]
19. Adoptive immunotherapy of poorly immunogenic tumors with in vitro sensitized cells generated by intratumoral administration of biological response modifiers. Mukai S; Kato H; Kimura S; Asai K; Kawahito Y; Inoue M; Yamamura Y; Sano H; Sugino S; Shu S Int J Immunopharmacol; 1995 Dec; 17(12):963-71. PubMed ID: 8964655 [TBL] [Abstract][Full Text] [Related]
20. Theophylline-resistant and theophylline-sensitive "active" and "total" E rosette-forming lymphocytes in patients with systemic scleroderma. Skopinska-Rózewska E; Majewski S; Błaszczyk M; Włodarska B; Jabłońska S J Invest Dermatol; 1988 Jun; 90(6):851-6. PubMed ID: 3259612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]